Disturbance of glucose homeostasis after pediatric cardiac surgery

Jennifer J Verhoeven1, Anita C S Hokken-Koelega, Marieke den Brinker

  • 1Intensive Care, Erasmus MC-Sophia Children's Hospital, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands. j.j.verhoeven@erasmusmc.nl

Pediatric Cardiology
|November 18, 2010
PubMed

Insights

Perioperative hyperglycemia is common in children undergoing cardiac surgery, often linked to glucocorticoid use. Blood glucose levels typically normalize within 24 hours without insulin, suggesting benefits may outweigh risks.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Congenital heart disease (CHD) necessitates complex cardiac surgeries in children.
  • Perioperative glycemic control is crucial but challenging in pediatric cardiac surgery.
  • Understanding factors influencing blood glucose levels is vital for optimizing patient outcomes.

Purpose of the Study:

  • To investigate the temporal patterns of blood glucose in pediatric cardiac surgery patients.
  • To correlate glucose levels with stress hormones, inflammatory markers, and exogenous factors.
  • To assess the incidence and resolution of hyperglycemia and its management.

Main Methods:

  • Prospective study of 49 children undergoing cardiac surgery for CHD.
  • Monitoring of blood glucose, stress hormones, and inflammatory mediators preoperatively and at 12, 24 hours postoperatively.
  • Analysis of exogenous factors including caloric intake and glucocorticoid administration.

Main Results:

  • Blood glucose levels peaked at the end of surgery, with 52% of children experiencing hyperglycemia (>8.3 mmol/l).
  • Glucocorticoid administration was significantly associated with end-of-surgery hyperglycemia.
  • Spontaneous blood glucose normalization occurred within 24 hours in 94% of patients without insulin therapy.

Conclusions:

  • Transient perioperative hyperglycemia is frequent in pediatric cardiac surgery but generally resolves spontaneously.
  • Glucocorticoid use is a primary driver of this hyperglycemia.
  • The benefits of perioperative glucocorticoids may outweigh the risks of iatrogenic hyperglycemia in this population, given low morbidity.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...